United Kingdom
Danny McMann
PartnerAbout
Danny McMann’s practice focuses on private equity. He represents private equity houses and financial sponsors and their portfolio companies on complex, cross-border and high value private equity and M&A transactions, across a range of industries and geographies.
Danny advises on all commercial legal matters, including acquisitions, carve-out transactions, exits, joint ventures, minority and growth capital investments, capital raises, transaction and equity structuring, management incentivisation, governance, due diligence and reputational, regulatory and compliance risks.
Danny was a private equity partner in the London office of a top-tier US law firm prior to joining DLA.
Professional QualificationsAttorney-at-law admitted with the Supreme Court of New York
EXPERIENCE
Since joining DLA Piper:
- MidEuropa on its acquisition of FAMAR, a leading European provider of pharmaceutical manufacturing and development services, from ECM Partners and Metric Capital Partners.
- AlterDomus, a leading global provider of end-to-end tech-enabled fund administration and corporate services, in connection with the company's EUR4.9bn sale by its Founders and Permira to Cinven.
- Warner Bros. Discovery and Liberty Global on their GBP1.15bn sale of All3Media, a British worldwide independent television, film and digital production and distribution company, to RedBird IMI.
- Dechra, a global developer and manufacturer of novel and differentiated generic animal health pharmaceuticals, in connection with equity arrangements following EQT’s GBP4.5bn takeover of the company.
- Statera Energy, a leading battery storage and flexible generation platform, in connection with the company's sale by InfraRed Capital Partners to EQT.
- OCS Group, a global facilities services provider, in connection with the company's sale to Clayton, Dubilier & Rice.
- Elida Beauty, a portfolio of consumer brands, in connection with the sale of the company by Unilever to Yellow Wood Partners.
- Dawsongroup, a leading independent asset leasing business, in connection with the company's sale by the Dawson family and other existing shareholders to KKR.
Prior to joining DLA Piper:
- Bain Capital:
- on its acquisition of a majority stake in Maesa, a global beauty brand incubator.
- on its acquisition of Bugaboo International, a Dutch design company that develops and produces mobility products.
- and Cinven on their EUR5.4bn joint public takeover of the German pharmaceutical company Stada Arzneimittel AG.
- and Carlyle on their EUR3.4bn joint public takeover offer for the German lighting company OSRAM Licht AG.
- and Advent International in structuring a management equity plan following their DKK17bn acquisition of card-payment company Nets Holding AS.
- EW Healthcare Partners:
- on its acquisition of a majority stake in the French pharmaceutical company Laboratoires Majorelle.
- on its EUR750m sale of EUSA Pharma.
- and Cognate BioServices on their acquisition of Cobra Biologics, a leading international contract development and manufacturing organization.
- on its sale of EUSA Pharma’s critical care business to SERB Pharmaceuticals.
- Starr Investment Holdings and ACA Compliance Group:
- on the acquisition of Cordium, a leading provider of governance, risk and compliance products and services, from Ares.
- on the sale of Cordium Malta Limited, a provider of compliance, risk, accounting and governance services for the investment management industry in Malta.
- on the sale of Wheelhouse Advisors (formerly Cordium Malta Limited), a compliance and accounting business, to Pelican Capital.
- Summit Partners:
- on the sale of its majority stake in Normec, a technology-enabled provider of testing, inspection and certification services, to Astorg.
- on its investment in Darktrace Limited, an AI company specialising in cyber security and defence systems.
- Davidson Kempner European Partners on its joint venture acquisition of the Urban Pubs & Bars business.
- SK Capital on its further investment in Archroma, a Swiss-headquartered provider of specialty chemicals.
- Siris Capital and Mavenir Group, a software provider for CSPs, in connection with Silver Rock’s USD125m preferred financing investment in the Mavenir Group.
- Starwood Capital Group:
- on its acquisition of a 29.42% stake in London-listed RDI Real Estate Investment Trust (REIT).
- on its investment in CASAFARI, a leading real estate data platform.
- Vitruvian Partners:
- on its investment in CFC Underwriting, an independent managing general agent.
- on its acquisition of Phlexglobal, provider of electronic Trial Master File systems and services to the life sciences industry, from Bridgepoint Development Capital.
- Indigo Capital on its sale of Premier Research, a leading middle-market contract research organisation, to Metalmark Capital.
- TowerBrook Capital Partners:
- on its acquisition of Dutch frozen food producer Van Geloven from Lion Capital.
- on its sale of a majority stake in Van Geloven to McCain Foods.
- on its sale of a minority stake in the TowerBrook group to Wafra.
- on its acquisition of the Metallum group, a European leader in metals trading, recycling and logistics, from Alpha.
Education
- Harvard Law School, J.D., 2014
- University of British Columbia, B.A. Medal in Arts: Head of Class, 2009
Prior Experience
Danny was a partner in the London office of a top-tier U.S. law firm prior to joining DLA.
